Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona. more
Time Frame | AXDX | Sector | S&P500 |
---|---|---|---|
1-Week Return | -9.09% | -3.39% | -3.47% |
1-Month Return | -33.33% | -3.25% | -0.29% |
3-Month Return | -18.37% | -11.61% | 4.5% |
6-Month Return | 3.45% | -5.89% | 6.91% |
1-Year Return | -73.45% | 2.65% | 23.79% |
3-Year Return | -97.51% | 0.56% | 28.43% |
5-Year Return | -99.29% | 34.63% | 83.64% |
10-Year Return | -99.34% | 94.78% | 185.94% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 9.30M | 11.16M | 11.78M | 12.75M | 12.06M | [{"date":"2019-12-31","value":72.91,"profit":true},{"date":"2020-12-31","value":87.55,"profit":true},{"date":"2021-12-31","value":92.39,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.57,"profit":true}] |
Cost of Revenue | 4.90M | 6.71M | 12.16M | 9.45M | 9.51M | [{"date":"2019-12-31","value":40.26,"profit":true},{"date":"2020-12-31","value":55.13,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":77.69,"profit":true},{"date":"2023-12-31","value":78.18,"profit":true}] |
Gross Profit | 4.40M | 4.46M | (381.00K) | 3.30M | 2.55M | [{"date":"2019-12-31","value":98.68,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-8.54,"profit":false},{"date":"2022-12-31","value":74.07,"profit":true},{"date":"2023-12-31","value":57.19,"profit":true}] |
Gross Margin | 47.33% | 39.94% | (3.23%) | 25.90% | 21.15% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":84.39,"profit":true},{"date":"2021-12-31","value":-6.83,"profit":false},{"date":"2022-12-31","value":54.73,"profit":true},{"date":"2023-12-31","value":44.68,"profit":true}] |
Operating Expenses | 77.23M | 68.16M | 71.18M | 66.11M | 56.58M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":88.25,"profit":true},{"date":"2021-12-31","value":92.16,"profit":true},{"date":"2022-12-31","value":85.6,"profit":true},{"date":"2023-12-31","value":73.26,"profit":true}] |
Operating Income | (72.83M) | (63.70M) | (71.56M) | (62.80M) | (54.03M) | [{"date":"2019-12-31","value":-7283100000,"profit":false},{"date":"2020-12-31","value":-6370000000,"profit":false},{"date":"2021-12-31","value":-7156000000,"profit":false},{"date":"2022-12-31","value":-6280500000,"profit":false},{"date":"2023-12-31","value":-5402800000,"profit":false}] |
Total Non-Operating Income/Expense | (23.03M) | (29.20M) | (21.55M) | (2.98M) | (12.48M) | [{"date":"2019-12-31","value":-2303200000,"profit":false},{"date":"2020-12-31","value":-2919800000,"profit":false},{"date":"2021-12-31","value":-2155400000,"profit":false},{"date":"2022-12-31","value":-298500000,"profit":false},{"date":"2023-12-31","value":-1247700000,"profit":false}] |
Pre-Tax Income | (84.42M) | (78.20M) | (77.66M) | (62.57M) | (60.77M) | [{"date":"2019-12-31","value":-8441600000,"profit":false},{"date":"2020-12-31","value":-7820300000,"profit":false},{"date":"2021-12-31","value":-7765700000,"profit":false},{"date":"2022-12-31","value":-6257000000,"profit":false},{"date":"2023-12-31","value":-6076800000,"profit":false}] |
Income Taxes | (111.00K) | 5.00K | 45.00K | (77.00K) | 850.00K | [{"date":"2019-12-31","value":-13.06,"profit":false},{"date":"2020-12-31","value":0.59,"profit":true},{"date":"2021-12-31","value":5.29,"profit":true},{"date":"2022-12-31","value":-9.06,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | (84.31M) | (78.21M) | (77.70M) | (62.49M) | (61.62M) | [{"date":"2019-12-31","value":-8430500000,"profit":false},{"date":"2020-12-31","value":-7820800000,"profit":false},{"date":"2021-12-31","value":-7770200000,"profit":false},{"date":"2022-12-31","value":-6249300000,"profit":false},{"date":"2023-12-31","value":-6161800000,"profit":false}] |
Income From Continuous Operations | (84.31M) | (78.21M) | (77.70M) | (62.49M) | (63.23M) | [{"date":"2019-12-31","value":-8430500000,"profit":false},{"date":"2020-12-31","value":-7820800000,"profit":false},{"date":"2021-12-31","value":-7770200000,"profit":false},{"date":"2022-12-31","value":-6249300000,"profit":false},{"date":"2023-12-31","value":-6322900000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (84.31M) | (78.21M) | (77.70M) | (62.49M) | (61.62M) | [{"date":"2019-12-31","value":-8430500000,"profit":false},{"date":"2020-12-31","value":-7820800000,"profit":false},{"date":"2021-12-31","value":-7770200000,"profit":false},{"date":"2022-12-31","value":-6249300000,"profit":false},{"date":"2023-12-31","value":-6161800000,"profit":false}] |
EPS (Diluted) | (1.54) | (1.40) | (1.27) | (0.76) | (2.15) | [{"date":"2019-12-31","value":-154,"profit":false},{"date":"2020-12-31","value":-140,"profit":false},{"date":"2021-12-31","value":-127,"profit":false},{"date":"2022-12-31","value":-76,"profit":false},{"date":"2023-12-31","value":-215,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
AXDX | |
---|---|
Cash Ratio | 1.15 |
Current Ratio | 1.50 |
Quick Ratio | 1.34 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
AXDX | |
---|---|
ROA (LTM) | -75.85% |
ROE (LTM) | 0.00% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
AXDX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 2.50 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -1.50 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
AXDX | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 2.46 |
P/B | 0.00 |
Price/FCF | NM |
EV/R | 5.61 |
EV/Ebitda | NM |
PEG | NM |
Accelerate Diagnostics Inc (AXDX) share price today is $1.22
Yes, Indians can buy shares of Accelerate Diagnostics Inc (AXDX) on Vested. To buy Accelerate Diagnostics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AXDX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Accelerate Diagnostics Inc (AXDX) via the Vested app. You can start investing in Accelerate Diagnostics Inc (AXDX) with a minimum investment of $1.
You can invest in shares of Accelerate Diagnostics Inc (AXDX) via Vested in three simple steps:
The 52-week high price of Accelerate Diagnostics Inc (AXDX) is $4.41. The 52-week low price of Accelerate Diagnostics Inc (AXDX) is $0.73.
The price-to-earnings (P/E) ratio of Accelerate Diagnostics Inc (AXDX) is
The price-to-book (P/B) ratio of Accelerate Diagnostics Inc (AXDX) is 0.00
The dividend yield of Accelerate Diagnostics Inc (AXDX) is 0.00%
The market capitalization of Accelerate Diagnostics Inc (AXDX) is $30.05M
The stock symbol (or ticker) of Accelerate Diagnostics Inc is AXDX